Expert Opinion on Therapeutic Patents (EOTP)

Publisher : Taylor & Francis

pharmaceutical patent claims providing expert opinion the scope for future development therapeutic potential

Claim Your Journal Get PRC Visit Website

e-ISSN 1744-7674

p-ISSN 1354-3776

Issue Frequency Monthly

Impact Factor 5.4

Est. Year 1991

Mobile 4402080520500

DOI YES

Language English

APC YES

Impact Factor Assignee GOOGLE SCHOLAR

Email enquiries@taylorandfrancis.com

Journal Descriptions

Expert Opinion on Therapeutic Patents (ISSN 1354-3776 [print], 1744-7674 [electronic]) is a MEDLINE-indexed, peer-reviewed, international subscription-based journal publishing review articles on recent pharmaceutical patent claims, providing expert opinion the scope for future development, in the context of the scientific literature. The Editors welcome: Reviews covering recent patent claims on compounds or applications with therapeutic potential, including biotherapeutics and small-molecule agents with specific molecular targets; and patenting trends in a particular therapeutic area Patent Evaluations examining the aims and chemical and biological claims of individual patents Perspectives on issues relating to intellectual property The audience consists of scientists, managers and decision-makers in the pharmaceutical industry and others closely involved in R&D Comprehensive coverage in each review is complemented by the unique Expert Collection format and includes the following sections: Expert Opinion - a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results. Article Highlights - an executive summary of the author's most critical points. Once your paper has been assessed for suitability by the Editorial Team, it will then be double-anonymous peer-reviewed by independent, expert referees.

Expert Opinion on Therapeutic Patents (EOTP) is :-

International, Peer-Reviewed, Open Access, Refereed, pharmaceutical patent claims, providing expert opinion the scope for future development, therapeutic potential, biotherapeutics and small-molecule agents, molecular targets, chemical and biological claims , Online or Print , Monthly Journal
UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1354-3776, E-ISSN: 1744-7674, Established: 1991, Impact Factor: 5.4
Provides Crossref DOI
Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE